{"href":"https://api.simplecast.com/oembed?url=https%3A%2F%2Fmedicalspecialtiespodcast.simplecast.com%2Fepisodes%2Fpbc-nonresponse-N9NpslWx","width":444,"version":"1.0","type":"rich","title":"Defining Nonresponse to PBC Treatment: Curbside Consults Podcast","thumbnail_width":300,"thumbnail_url":"https://image.simplecastcdn.com/images/26d7523c-7315-48a0-9da6-29d252d3ce90/2f3c636d-2224-4b1f-8878-244524999b19/100297-pbc-curbside-consult-vm-id-v1-podcast-title-3000x3000.jpg","thumbnail_height":300,"provider_url":"https://simplecast.com","provider_name":"Simplecast","html":"<iframe src=\"https://player.simplecast.com/a12da002-445c-4f73-ba0a-e9a7a931a92e\" height=\"200\" width=\"100%\" title=\"Defining Nonresponse to PBC Treatment: Curbside Consults Podcast\" frameborder=\"0\" scrolling=\"no\"></iframe>","height":200,"description":"How do you decide when to move from first-line to second-line treatment for primary biliary cholangitis (PBC)? In this podcast, listen as experts Alan Bonder, MD, AGAF, and Aparna Goel, MD, discuss this question and more, including how and when to measure treatment response; evidence-based goals of therapy; and considerations for second-line treatment."}